These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 4821860

  • 1. Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography.
    Chang SY, Lakings DB, Zumwalt RW, Gehrke CW, Waalkes TP.
    J Lab Clin Med; 1974 May; 83(5):816-30. PubMed ID: 4821860
    [No Abstract] [Full Text] [Related]

  • 2. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.
    Waalkes TP, Dinsmore SR, Mrochek JE.
    J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877
    [No Abstract] [Full Text] [Related]

  • 3. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP, Gehrke CW, Zumwalt RW, Chang SY, Lakings DB, Tormey DC, Ahmann DL, Moertel CG.
    Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
    [Abstract] [Full Text] [Related]

  • 4. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients.
    Mrochek JE, Dinsmore SR, Waalkes TP.
    J Natl Cancer Inst; 1974 Dec; 53(6):1553-63. PubMed ID: 4474409
    [No Abstract] [Full Text] [Related]

  • 5. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
    Lehtiö H, Mäenpää PH.
    Clin Chim Acta; 1977 Oct 01; 80(1):181-5. PubMed ID: 908140
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI, McClure TD, el-Shakawi S, Fielding A, Schram KH, Newton RP.
    Rapid Commun Mass Spectrom; 1993 Jun 01; 7(6):427-34. PubMed ID: 8329765
    [Abstract] [Full Text] [Related]

  • 12. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA, Grever MR, Speicher CE, Trewyn RW.
    J Lab Clin Med; 1983 May 01; 101(5):783-92. PubMed ID: 6572681
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
    Tormey DC, Waalkes TP, Gehrke CW.
    J Surg Oncol; 1980 May 01; 14(3):267-73. PubMed ID: 7392649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Possible use of urinary modified RNA metabolites in the measurement of RNA turnover in the human body.
    Sander G, Topp H, Wieland J, Heller-Schöch G, Schöch G.
    Hum Nutr Clin Nutr; 1986 Mar 01; 40(2):103-18. PubMed ID: 2420752
    [Abstract] [Full Text] [Related]

  • 18. Isolation and identification of urinary nucleosides. Applications of high-performance liquid chromatographic methods to the synthesis of 5'-deoxyxanthosine and the simultaneous determination of 5,6-dihydrouridine and pseudouridine.
    Nakano K, Yasaka T, Schram KH, Reimer ML, McClure TD, Nakao T, Yamamoto H.
    J Chromatogr; 1990 Aug 31; 515():537-46. PubMed ID: 2283377
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.